Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events
Top Cited Papers
- 29 June 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (25_suppl_1) , IV-6-IV-19
- https://doi.org/10.1161/01.cir.0000133444.17867.56
Abstract
No abstract availableThis publication has 136 references indexed in Scilit:
- Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular eventsCurrent Opinion in Cardiology, 2003
- Plasma oxidized LDL: a predictor for acute myocardial infarction?Journal of Internal Medicine, 2003
- Role of oxidative stress in atherosclerosisThe American Journal of Cardiology, 2003
- Oxidized LDL-Induced Smooth Muscle Cell Proliferation Involves the EGF Receptor/PI-3 Kinase/Akt and the Sphingolipid Signaling PathwaysArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Inhibition of LOX-1 by Statins May Relate to Upregulation of eNOSBiochemical and Biophysical Research Communications, 2001
- Plasminogen-Activator Inhibitor Type 1 and Coronary Artery DiseaseNew England Journal of Medicine, 2000
- The Effect of Folic Acid Fortification on Plasma Folate and Total Homocysteine ConcentrationsNew England Journal of Medicine, 1999
- 8‐hydroxydeoxyguanosine as a urinary biomarker of oxidative DNA damageJournal of Toxicology and Environmental Health, 1993
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984